• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低分子量因子VIII与金颗粒结合后血管性血友病因子活性增加]

[Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].

作者信息

Furlan M, Perret B A, Beck E A

出版信息

Schweiz Med Wochenschr. 1980 Oct 4;110(40):1456-8.

PMID:6792697
Abstract

High molecular weight factor VIII was partially reduced with beta-mercaptoethanol. Disulfide reduction resulted in progressive dissociation of the multimeric protein with a concomitant decrease in von Willebrand activity. The binding of reduced small factor VIII oligomers to gold particles with an average diameter of 20--25 nm led to marked "activation" of their von Willebrand activity. A similar increase in activity was also observed following adsorption of native small molecular weight forms of factor VIII to gold granules. Binding of initially highly active high molecular weight factor VIII to gold granules resulted in inhibition of von Willebrand activity, probably by formation of superaggregates. The platelet aggregating function of factor VIII in the circulation appears to depend largely on the size of this multimeric protein, which must be in the range of several millions for its maximum expression.

摘要

高分子量凝血因子VIII被β-巯基乙醇部分还原。二硫键的还原导致多聚体蛋白逐渐解离,同时血管性血友病因子活性降低。还原后的小分子量凝血因子VIII寡聚体与平均直径为20 - 25 nm的金颗粒结合,导致其血管性血友病因子活性显著“激活”。将天然小分子量形式的凝血因子VIII吸附到金颗粒上后,也观察到类似的活性增加。最初高活性的高分子量凝血因子VIII与金颗粒结合导致血管性血友病因子活性受到抑制,这可能是由于形成了超聚集体。循环中凝血因子VIII的血小板聚集功能似乎很大程度上取决于这种多聚体蛋白的大小,其最大表达时大小必须在数百万范围内。

相似文献

1
[Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].[低分子量因子VIII与金颗粒结合后血管性血友病因子活性增加]
Schweiz Med Wochenschr. 1980 Oct 4;110(40):1456-8.
2
Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.低分子量人凝血因子VIII的血管性血友病因子活性通过与金颗粒结合而增加。
Thromb Haemost. 1981 Jun 30;45(3):242-6.
3
Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.因子VIII/血管性血友病因子的二硫键与四级结构
J Clin Invest. 1978 Sep;62(3):702-9. doi: 10.1172/JCI109178.
4
Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets.论文:瑞斯托霉素(R)、血管性血友病因子(vWF)、凝血因子 VIII 活性(VIIIc)与血小板的相互作用
Thromb Diath Haemorrh. 1975 Nov 15;34(2):582.
5
Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
Thromb Haemost. 1978 Oct 31;40(2):302-15.
6
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.凝血因子VIII/血管性血友病因子蛋白。半乳糖是血管性血友病因子活性的一个隐蔽决定因素。
J Clin Invest. 1978 Aug;62(2):496-9. doi: 10.1172/JCI109152.
7
Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.人类抗血友病因子的研究。共价连接亚基结构的证据。
J Clin Invest. 1976 Apr;57(4):925-37. doi: 10.1172/JCI108369.
8
Molecular genetics of von Willebrand disease.血管性血友病的分子遗传学
Ann Genet. 1998;41(1):34-43.
9
Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.与因子VIII结合缺陷的血管性血友病变异型:日本首例病例。
Int J Hematol. 1993 Apr;57(2):163-73.
10
Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.在一名因子VIII结合缺陷患者的血管性血友病因子中鉴定出His54Gln替代。
Am J Hematol. 1996 Apr;51(4):302-6. doi: 10.1002/(SICI)1096-8652(199604)51:4<302::AID-AJH9>3.0.CO;2-#.